RYVYX
Price
$815.16
Change
-$33.88 (-3.99%)
Updated
Jun 10 closing price
Net Assets
1.69B
UGPIX
Price
$16.05
Change
-$0.27 (-1.65%)
Updated
Jun 10 closing price
Net Assets
19.56M
Interact to see
Advertisement

RYVYX vs UGPIX

Header iconRYVYX vs UGPIX Comparison
Open Charts RYVYX vs UGPIXBanner chart's image
RYVYX vs UGPIX Comparison Chart in %
View a ticker or compare two or three
VS
RYVYX vs. UGPIX commentary
Jun 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVYX is a Hold and UGPIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVYX has more cash in the bank: 1.69B vs. UGPIX (19.6M). UGPIX pays higher dividends than RYVYX: UGPIX (8.67) vs RYVYX (0.00). RYVYX was incepted earlier than UGPIX: RYVYX (26 years) vs UGPIX (18 years). RYVYX (1.87) is less costly to investors than UGPIX (1.70). RYVYX is a more actively managed with annual turnover of: 383.00 vs. UGPIX (254.00). RYVYX has a lower initial minimum investment than UGPIX: RYVYX (2500) vs UGPIX (15000). RYVYX annual gain was more profitable for investors over the last year : 51.01 vs. UGPIX (-29.97). RYVYX return over 5 years is better than : 122.75 vs. UGPIX (-89.74).
RYVYXUGPIXRYVYX / UGPIX
Total Expense Ratio1.741.70102%
Annual Report Gross Expense Ratio1.871.70110%
Fund Existence26 years18 years-
Gain YTD27.700-35.392-78%
Front LoadN/AN/A-
Min. Initial Investment25001500017%
Min. Initial Investment IRAN/AN/A-
Net Assets1.69B19.6M8,602%
Annual Yield % from dividends0.008.67-
Returns for 1 year51.01-29.97-170%
Returns for 3 years165.23-30.59-540%
Returns for 5 years122.75-89.74-137%
Returns for 10 years1077.59-77.82-1,385%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRIEX8.42N/A
N/A
CRM All Cap Value Inst
SVTAX10.84N/A
N/A
SEI Global Managed Volatility F (SIMT)
FOCIX15.54N/A
N/A
Fairholme Focused Income
MVISX57.02N/A
N/A
Patient Opportunity IS
MKVGX18.47N/A
N/A
MFS International Large Cap Value R4